|
1
|
Saito T, Nishimura M, Kudo R and Yamasaki
H: Suppressed gap junctional intercellular communication in
carcinogenesis of endometrium. Int J Cancer. 93:317–323. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishimura M, Saito T, Yamasaki H and Kudo
R: Suppression of gap junctional intercellular communication via 5′
CpG island methylation in promoter region of E-cadherin gene in
endometrial cancer cells. Carcinogenesis. 24:1615–1623. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geletu M, Chaize C, Arulanandam R, Vultur
A, Kowolik C, Anagnostopoulou A, Jove R and Raptis L: Stat3
activity is required for gap junctional permeability in normal rat
liver epithelial cells. DNA Cell Biol. 28:319–327. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fujimoto E, Sato H, Shirai S, Nagashima Y,
Fukumoto K, Hagiwara H, Negishi E, Ueno K, Omori Y, Yamasaki H, et
al: Connexin32 as a tumor suppressor gene in a metastatic renal
cell carcinoma cell line. Oncogene. 24:3684–3690. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geletu M, Trotman-Grant A and Raptis L:
Mind the gap; regulation of gap junctional, intercellular
communication by the SRC oncogene product and its effectors.
Anticancer Res. 32:4245–4250. 2012.PubMed/NCBI
|
|
6
|
Geletu M, Arulanandam R, Greer S,
Trotman-Grant A, Tomai E and Raptis L: Stat3 is a positive
regulator of gap junctional intercellular communication in
cultured, human lung carcinoma cells. BMC Cancer. 12:6052012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guy S, Geletu M, Arulanandam R and Raptis
L: Stat3 and gap junctions in normal and lung cancer cells. Cancers
(Basel). 6:646–662. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sánchez JA, Rodríguez-Sinovas A, Barba I,
Miró-Casas E, Fernández-Sanz C, Ruiz-Meana M, Alburquerque-Béjar JJ
and García-Dorado D: Activation of RISK and SAFE pathways is not
involved in the effects of Cx43 deficiency on tolerance to
ischemia-reperfusion injury and preconditioning protection. Basic
Res Cardiol. 108:3512013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rajasingh J, Bord E, Hamada H, Lambers E,
Qin G, Losordo DW and Kishore R: STAT3-dependent mouse embryonic
stem cell differentiation into cardiomyocytes: Analysis of
molecular signaling and therapeutic efficacy of cardiomyocyte
precommitted mES transplantation in a mouse model of myocardial
infarction. Circ Res. 101:910–918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wincewicz A, Koda M, Sulkowska M,
Kanczuga-Koda L and Sulkowski S: Comparison of STAT3 with
HIF-1alpha, Ob and ObR expressions in human endometrioid
adenocarcinomas. Tissue Cell. 40:405–410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
World Medical Association. 2004.WMA
declaration of Helsinki: Ethical principles for medical research
involving human subjects. http://www.wma.net/en/30publications/10policies/b3/Accessed.
January. 2016
|
|
12
|
Lesniewicz T, Kanczuga-Koda L, Baltaziak
M, Jarzabek K, Rutkowski R, Koda M, Wincewicz A, Sulkowska M and
Sulkowski S: Comparative evaluation of estrogen and progesterone
receptor expression with connexins 26 and 43 in endometrial cancer.
Int J Gynecol Cancer. 19:1253–1257. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wincewicz A, Baltaziak M, Kanczuga-Koda L,
Koda M, Sulkowska U, Famulski W and Sulkowski S: STAT3 and
apoptosis regulators: Bak and Bcl-xL in endometrioid
adenocarcinomas of different estrogen receptor-α immunoprofile.
Gynecol Endocrinol. 27:536–540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kanczuga-Koda L, Wincewicz A, Fudala A,
Abrycki T, Famulski W, Baltaziak M, Sulkowski S and Koda M:
E-cadherin and β-catenin adhesion proteins correlate positively
with connexins in colorectal cancer. Oncol Lett. 7:1863–1870.
2014.PubMed/NCBI
|
|
15
|
Saito T, Tanaka R, Wataba K, Kudo R and
Yamasaki H: Overexpression of estrogen receptor-alpha gene
suppresses gap junctional intercellular communication in
endometrial carcinoma cells. Oncogene. 23:1109–1116. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang JZ, Kong XJ, Banerjee A, Muniraj N,
Pandey V, Steiner M, Perry JK, Zhu T, Liu DX and Lobie PE:
STAT3alpha is oncogenic for endometrial carcinoma cells and
mediates the oncogenic effects of autocrine human growth hormone.
Endocrinology. 151:4133–4145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ozog MA, Bernier SM, Bates DC, Chatterjee
B, Lo CW and Naus CC: The complex of ciliary neurotrophic
factor-ciliary neurotrophic factor receptor alpha up-regulates
connexin43 and intercellular coupling in astrocytes via the Janus
tyrosine kinase/signal transducer and activator of transcription
pathway. Mol Biol Cell. 15:4761–4764. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lesniewicz T, Kanczuga-Koda L, Baltaziak
M, Sulkowska M, Rutkowski R, Koda M and Sulkowski S: Expression of
connexin 26 in endometrial adenocarcinoma-analysis of correlations
with some anatomoclinical features. Folia Histochem Cytobiol.
46:171–176. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Teleki I, Szasz AM, Maros ME, Gyorffy B,
Kulka J, Meggyeshazi N, Kiszner G, Balla P, Samu A and Krenacs T:
Correlations of differentially expressed gap junction connexins
Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and
prognosis. PLoS One. 9:e1125412014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Teleki I, Krenacs T, Szasz MA, Kulka J,
Wichmann B, Leo C, Papassotiropoulos B, Riemenschnitter C, Moch H
and Varga Z: The potential prognostic value of connexin 26 and 46
expression in neoadjuvant-treated breast cancer. BMC Cancer.
13:502013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schlemmer SR, Novotny DB and Kaufman DG:
Changes in connexin 43 protein expression in human endometrial
carcinoma. Exp Mol Pathol. 67:150–163. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakamura Y, Chang CC, Mori T, Sato K,
Ohtsuki K, Upham BL and Trosko JE: Augmentation of differentiation
and gap junction function by kaempferol in partially differentiated
colon cancer cells. Carcinogenesis. 26:665–671. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Méndez-López LF, Dávila-Rodríguez MI,
Zavala-Pompa A, Torres-López E, González-Martínez BE and
López-Cabanillas-Lomelí M: Expression of leptin receptor in
endometrial biopsies of endometrial and ovarian cancer patients.
Biomed Rep. 1:659–663. 2013.PubMed/NCBI
|
|
24
|
Lay V, Yap J, Sonderegger S and
Dimitriadis E: Interleukin 11 regulates endometrial cancer cell
adhesion and migration via STAT3. Int J Oncol. 41:759–764.
2012.PubMed/NCBI
|
|
25
|
Yang J, Liu B, Wang Q, Yuan D, Hong X,
Yang Y and Tao L: Connexin 32 and its derived homotypic gap
junctional intercellular communication inhibit the migration and
invasion of transfected HeLa cells via enhancement of intercellular
adhesion. Mol Med Rep. 4:971–979. 2011.PubMed/NCBI
|
|
26
|
Zhu M, Che Q, Liao Y, Wang H, Wang J, Chen
Z, Wang F, Dai C and Wan X: Oncostatin M activates STAT3 to promote
endometrial cancer invasion and angiogenesis. Oncol Rep.
34:129–138. 2015.PubMed/NCBI
|
|
27
|
Sulkowska U, Wincewicz A, Kanczuga-Koda L,
Koda M and Sulkowski S: Eventual proapoptotic or anti-apoptotic
impact of aberrantly expressed Cx43 and Cx26 can depend on ER-alpha
overexpression in human endometrioid adenocarcinoma. Gynecol
Endocrinol. 31:604–608. 2015. View Article : Google Scholar : PubMed/NCBI
|
